[Active surveillance for the secondary prevention of prostate cancer]

Prog Urol. 2012 Feb;22(2 Suppl 1):H10-4. doi: 10.1016/S1166-7087(12)70026-X.

[Article in French]

Authors

T Seisen¹, M Rouprêt, A R Azzouzi, O Cussenot, F Rozet

Affiliation

¹ Service d'Urologie de l'Hôpital Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, Université Paris VI, Faculté de médecine Pierre et Marie Curie, France, 47-83, boulevard de l'Hôpital, 75013 Paris, France.

PMID: 22445521
DOI: 10.1016/S1166-7087(12)70026-X

No abstract available

MeSH terms

Humans
Male
Neoplasm Staging
Prostate-Specific Antigen / blood
Prostatic Neoplasms / pathology
Prostatic Neoplasms / prevention & control*
Secondary Prevention*
Watchful Waiting

Substances

Prostate-Specific Antigen